Gene · 1294
Papers2,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pretibial epidermolysis bullosa: compound heterozygous variants in a rare dystrophic epidermolysis bullosa subtype. | Dermatol Online J | 2025 | 41725472 | PubTator, text mining | PubMed |
| Case report: Epidermolysis bullosa acquisita following dipeptidyl peptidase-4 inhibitor therapy and complicated by immune thrombocytopenic purpura. | Front Immunol | 2025 | 41562089 | PubTator, text mining | PubMed |
| Scarring Alopecia in Localized Dystrophic Epidermolysis Bullosa: A Case Report and a Scoping Review. | Cureus | 2025 | 41523446 | PubTator, text mining | PubMed |
| Epigenetic Clocks in Skin Aging: From Exposome Drivers to Biomarkers and Therapeutic Interventions. | Clin Cosmet Investig Dermatol | 2025 | 41498118 | PubTator, text mining | PubMed |
| Human urine-derived stem cells rescue cutaneous manifestation and suppress inflammation and fibrosis in vitro and in a mouse model of recessive dystrophic epidermolysis bullosa. | Burns Trauma | 2025 | 41403889 | PubTator, text mining | PubMed |
| IPSC-derived organoid-sourced skin cells enable functional 3D skin modeling of recessive dystrophic epidermolysis bullosa. | J Tissue Eng | 2025 | 41340774 | PubTator, text mining | PubMed |
| Localized dominant dystrophic epidermolysis bullosa worsened by diabetes. | Eur J Dermatol | 2025 | 41277647 | PubTator, text mining | PubMed |
| Multi-scale cancer driver gene prediction by flexible data selection and network topology guidance. | J Biomed Inform | 2025 | 41276241 | PubTator, text mining | PubMed |
| Nano- and Microscale Chemical and Topographical Patterning of Synthetic Cell Scaffolds: from Hard to Soft Materials. | ACS Mater Au | 2025 | 41245567 | PubTator, text mining | PubMed |
| Integration of bulk and single-cell transcriptomic data reveals a novel signature related to liver metastasis and basement membrane in pancreatic cancer. | Front Immunol | 2025 | 41235257 | PubTator, text mining | PubMed |
| Novel eRF3a degrader enhances gentamicin-induced premature termination codon readthrough in epidermolysis bullosa. | Mol Ther Nucleic Acids | 2025 | 41210582 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic Variations in Pancreatic Adenocarcinoma by Race. | Cancer Med | 2025 | 41187942 | PubTator, text mining | PubMed |
| The immunophenotype of immune checkpoint-induced bullous pemphigoid: a cohort study. | Cancer Immunol Immunother | 2025 | 41182473 | PubTator, text mining | PubMed |
Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase. | EClinicalMedicine | 2025 | 41181851 | PubTator, text mining | PubMed |
| MicroRNA strand ratio disarray promotes temozolomide resistance in glioblastoma. | Cell Mol Biol Lett | 2025 | 41174475 | PubTator, text mining | PubMed |
| Bullous Systemic Lupus Erythematosus As the Initial Presentation of Systemic Lupus Erythematosus. | Cureus | 2025 | 41141000 | PubTator, text mining | PubMed |
| Lyme Disease Causing Complex Bullous Lesions: A Case Report. | Cureus | 2025 | 41133080 | PubTator, text mining | PubMed |
| Collagen XII is Commonly Downregulated in the Dermal Extracellular Matrix in Diverse Skin Pathologies. | MedComm (2020) | 2025 | 41127504 | PubTator, text mining | PubMed |
| Excessive collagen type VII mediates pleural fibrosis via increasing extracellular matrix stiffness. | J Clin Invest | 2025 | 41100460 | PubTator, text mining | PubMed |
| Transcriptomic analysis in peripheral blood mononuclear cells from hyper and hypo weight-loss responders. | Genes Nutr | 2025 | 41087885 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1294/papers?page=4